🇺🇸 FDA
Pipeline program

KIg10

KB072

Phase 3 small_molecule active

Quick answer

KIg10 for Chronic Immune Thrombocytopenia (ITP) is a Phase 3 program (small_molecule) at Kedrion S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Kedrion S.p.A.
Indication
Chronic Immune Thrombocytopenia (ITP)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials